NCT00019565View on ClinicalTrials.gov

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

August 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
PROCEDURE

magnetic resonance imaging

PROCEDURE

positron emission tomography

RADIATION

fludeoxyglucose F 18

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00019565 - PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy | Biotech Hunter | Biotech Hunter